---
$id: https://graph.org.ai/products/commodity/51282311
$type: Product
source: UNSPSC
code: "51282311"
title: "Clarithromycin lactobionate"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clarithromycin lactobionate

**UNSPSC Code**: 51282311
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic C38H69NO13.C12H22O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4108JKI097, chemically known as erythromycin, 6-o-methyl-, 4-o-.beta.-d-galactopyranosyl-d-gluconate (1:1), but more generally known as clarithromycin lactobionate, which bears US NIH Compound Identifier 178265. European Medicines Agency schedules Clarithromycin lactobionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20333. Most nations, for tariff and trade purposes, schedule clarithromycin lactobionate under HS 29415000 and SITC 54139. SMILES: As of Q4 2014, CLARITHROMYCIN LACTOBIONATE remains US FDA's Preferred Term for this commodity.

